Unavailable From Mid October!
MHRA has issued an alert via the Central Alert System for Tinzaparin sodium (10,000 IU/ml) 3,500 units in 0.35ml and 4,500 units in 0.45ml pre-filled syringes – Supply Disruption
These will be unavailable between middle of October 2021 and January 2022 (date TBC).
All other presentations of tinzaparin remain unaffected by this supply disruption.
Organisations who use tinzaparin for both prophylaxis and treatment of venous thromboembolism will need to consider if they wish to switch to an alternative low molecular weight heparin (LMWH) for all indications or just for prophylaxis
Click here for the full source guidance
